Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMED | Common Stock | Award | $0 | +1.36K | +26.31% | $0.00 | 6.54K | Feb 23, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMED | Stock Option (Right to Buy) | Award | $0 | +2.88K | $0.00 | 2.88K | Feb 23, 2023 | Common Stock | 2.88K | $91.77 | Direct | F2 | |
transaction | AMED | Restricted Stock Unit (Performance-Based Vesting) | Award | $0 | +2.73K | $0.00 | 2.73K | Feb 23, 2023 | Common Stock | 2.73K | Direct | F3 |
Id | Content |
---|---|
F1 | The Issuer awarded the Reporting Person 1,363 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date. |
F2 | The Stock Options are subject to time-based vesting conditions and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date. |
F3 | The performance-based RSUs will cliff vest following a three-year performance period ending December 31, 2025 based on the Company's achievement of a pre-established performance measure for 2023, as modified by the Company's three-year total shareholder return percentile rank compared to a pre-established comparator group. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0% to 200% of the amount reported depending on the level of performance achieved. |